当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析 - 现金流量表

凯赛生物

(688065)

  

流通市值:219.82亿  总市值:271.78亿
流通股本:5.83亿   总股本:7.21亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,709,544,187.031,870,780,668.33564,116,3013,213,367,293.82
  收到的税费返还51,530,208.9733,727,234.122,155,636.2945,619,840.68
  收到其他与经营活动有关的现金391,709,363.32315,920,844.1990,093,230.11379,418,388.05
  经营活动现金流入小计3,152,783,759.322,220,428,746.62676,365,167.43,638,405,522.55
  购买商品、接受劳务支付的现金1,958,269,658.711,122,618,596.89518,616,205.592,393,163,432.82
  支付给职工以及为职工支付的现金244,993,971.45159,715,663.1888,159,702.97293,181,079.26
  支付的各项税费182,901,001.2134,090,087.3160,974,599.04334,870,029.52
  支付其他与经营活动有关的现金150,010,952.2353,405,166.4329,609,273.71213,067,883.27
  经营活动现金流出小计2,536,175,583.591,469,829,513.81697,359,781.313,234,282,424.87
  经营活动产生的现金流量净额平衡项目00.0100
  经营活动产生的现金流量净额616,608,175.73750,599,232.82-20,994,613.91404,123,097.68
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,844,142.19502,739.72-13,633,363.6
  处置固定资产、无形资产和其他长期资产收回的现金净额---35,155,295.77
  收到的其他与投资活动有关的现金1,055,712,000355,712,0005,712,0003,503,590,096.8
  投资活动现金流入小计1,057,556,142.19356,214,739.725,712,0003,552,378,756.17
  购建固定资产、无形资产和其他长期资产支付的现金835,704,630.07552,044,845.61295,347,599.73743,459,192.81
  投资支付的现金56,625,742.6656,625,742.6696,625,742.6625,500,000
  取得子公司及其他营业单位支付的现金78,096,586.7178,096,586.71--
  支付其他与投资活动有关的现金1,200,000,000350,000,000-3,509,302,096.8
  投资活动现金流出小计2,170,426,959.441,036,767,174.98391,973,342.394,278,261,289.61
  投资活动产生的现金流量净额-1,112,870,817.25-680,552,435.26-386,261,342.39-725,882,533.44
三、筹资活动产生的现金流量:
  吸收投资收到的现金---5,967,224,993.63
  其中:子公司吸收少数股东投资收到的现金---52,500,000
  取得借款收到的现金915,216,593.58722,313,187.49634,683,745.09758,403,967.5
  收到其他与筹资活动有关的现金--854,00029,359,500
  筹资活动现金流入小计915,216,593.58722,313,187.49635,537,745.096,754,988,461.13
  偿还债务支付的现金527,701,415.11521,041,236.8710,500,0002,125,721,348.53
  分配股利、利润或偿付利息支付的现金334,080,548.656,416,002.022,984,968.76313,131,536.23
  支付其他与筹资活动有关的现金---946,253.97
  筹资活动现金流出小计861,781,963.76527,457,238.8913,484,968.762,439,799,138.73
  筹资活动产生的现金流量净额53,434,629.82194,855,948.6622,052,776.334,315,189,322.4
四、汇率变动对现金及现金等价物的影响-142,559,665.98-117,899,096.93-58,707,879.13-58,919,577.52
五、现金及现金等价物净增加额-585,387,677.68147,003,649.23156,088,940.93,934,510,309.12
  加:期初现金及现金等价物余额9,120,475,022.249,120,475,022.249,120,475,022.245,185,964,713.12
  期末现金及现金等价物余额8,535,087,344.569,267,478,671.479,276,563,963.149,120,475,022.24
补充资料:
  净利润-369,665,020.65-529,502,308.11
  资产减值准备-14,865,823.26-135,700,535.02
  固定资产和投资性房地产折旧-148,055,929.3-295,072,759.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-148,055,929.3-295,072,759.25
  无形资产摊销-11,560,776.55-20,518,535.01
  长期待摊费用摊销-1,469,682.68-3,374,031.62
  处置固定资产、无形资产和其他长期资产的损失-18,664.22--6,708,160.46
  固定资产报废损失-777,738.27-28,990.91
  财务费用-120,189,521.12-86,435,873.89
  投资损失-8,590,217.15--1,401,691.68
  递延所得税--7,993,370.17--67,750,463.49
  其中:递延所得税资产减少--7,767,195.37--67,750,463.49
    递延所得税负债增加--226,174.8--
  存货的减少-18,691,801.57--395,288,462.56
  经营性应收项目的减少--38,387,011.24--382,674,198.3
  经营性应付项目的增加-83,876,668.72-174,785,663.87
  其他-13,183,980.86-798,637.95
  现金的期末余额-9,267,478,671.47-9,120,475,022.24
  减:现金的期初余额-9,120,475,022.24-5,185,964,713.12
  现金及现金等价物的净增加额-147,003,649.23-3,934,510,309.12
公告日期2026-10-312026-08-202026-04-302026-04-24
审计意见(境内)标准无保留意见
TOP↑